Biologics Market

ethansmith

Biologics Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

2016

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com


Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas

Customized

Research

Syndicated

Research

Investment

Research

Social Media

Research

Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com


Report Description

Biologics are drugs in the form of genetically engineered proteins, derived from human

genes. As per the US FDA, biologics can be composed of sugars, proteins, or nucleic acids

or complex combinations of these substances, or may be living entities such as cells and

tissues. The biologic drugs are derived from a variety of natural sources such as humans,

animals, or microorganisms and consist of products, such as vaccines, blood and blood

components, allergenics, somatic cells, gene therapy, tissues, and recombinant

therapeutic proteins. Advanced biotechnology techniques and complex processes are

used to manufacture biologics. They are at the forefront of biomedical research.

Biologics Market: Drivers and Restraints

Drivers for the biologics market include big brand name drugs losing patent extensions,

growing incidence of chronic diseases and their diagnoses across the globe, increased

availability of advanced diagnostics, rising government initiatives in healthcare and

growing technological advancements in research and development across the globe by

big drug makers to sustain competition and invest in incremental innovation. Other

factors increasing the demand for biologic drugs include rising regulatory convergence

and better access to healthcare for all nations.

Restraints for the market include difficulty in manufacturing, as the drugs are highly

complex in nature. They must be processed under tightly controlled conditions/controls,

maintained throughout the production process. This type of atmosphere and quality

control procedures are not easily available in less developed nations. Environmental

contamination needs to be eliminated from the manufacturing process. Further, biologics


Report Description

Biologics Market: Segmentation

Biologics Market can be segmented into these following ways:

Segmentation by product type

Segmentation by application

Segmentation by source material

Browse Full Report@ http://www.futuremarketinsights.com/reports/biologics-market

Biologics Market: Overview

Biologics market is at risk over the forthcoming years due to leading biologic drugs

expected to lose exclusivity over the next seven years. The patented biologic drugs are

expected to be replaced by biosimilar drugs. Competition is expected to be limited in the

market as the drugs are expected to be formed using various types of innovative

technologies. Increasing geriatric population, early onset of ageing, increasing awareness

for technologically advanced medical procedures and drugs, higher spending power, and

rising incidence of chronic diseases such as cancer, rheumatoid arthritis, etc. are

expected to drive the market growth of biologic drugs.

Biologics Market: Region-wise Outlook

Depending on geographic regions, biologic drug market is segmented into seven key

regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific,


Report Description

Request Free Report Sample@

http://www.futuremarketinsights.com/reports/sample/rep-gb-1249

In terms of geography, North America and Europe dominate the market, followed by

Asia-Pacific. However, rising technological advancement in healthcare and systematic

drug review process will drive the markets over North America, Japan and other regions.

Europe currently dominates the biosimilars market driven by technically advanced

healthcare infrastructure and high patient awareness & regulatory harmonization.

Increasing funding for development of biologics available through public-private

partnerships, availability of high-quality research infrastructure and innovative strategies

developed by drug makers to restrict entry of new players are factors expected to

contribute to market growth of biologics over the forecast period. Emerging markets

include Eastern European countries followed by countries in Eastern Africa. Rising disease

incidences in these countries is expected to prove favorable for the growth of the

biologics market.

Download TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1249

Biologics Market: Key Players

Some of the key players in biologics market are Unilife Corporation, Retractable

Technologies, Inc., Smiths Medicals, Becton, Dickinson & Company, Smiths Medical,

Terumo Corporation, Pfizer Inc. (AC. Hospira), Roche Diagnostics, AstraZeneca, Bayer AG,

Genzyme, GSK Biologicals, Lundbeck, Novartis AG, and Merck KGaA.


Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

sales@futuremarketinsights.com

For other queries contact: Mr. Sudip Saha

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines